FDA Drug Approval Process February 2011

Feb 1, 2011


	Order the DVD of this seminar Single Copy - $695.00Site License - $1,695.00

Course Description

This course provides an overview of what is required to take a new drug from research to market. We will begin by reviewing the contents of an IND, and then follow the process of an IND submission. From there, we will discuss the contents and approval process of an NDA submission. This course will provide a foundation for those who require an understanding of the FDA new drug approval process, and help attendees become familiar with the regulatory landscape in which INDs and NDAs are developed and approved.

VideoPreview

Learning Objectives

Navigate the FDA approval process for a new drug
Describe what an IND is, and identify the contents of an IND
Describe what an NDA is, and identify the contents of an NDA
Discuss the FDA IND and NDA review process

Who Should Attend

Regulatory Affairs personnel, Quality personnel, Manufacturing personnel, Research personnel, Those who have to know about preparation of INDs and NDAs, Those who have to understand the FDA new drug approval process

Instructor

Albert A. Ghignone, MS, RAC

Click here for complete trainer biographies

Course Length Time

3 hours; 12:30 - 3:30 p.m. Eastern

Course Dates

February 1, 2011

Registration Fees

On-Demand GCP Refresher Training

Too busy to attend a course? Our newly-released GCP eLearning course may be your solution!
For details on our scenario-based practical GCP application on-demand course, click here.

Barnett "Hands-On" Workshops are designed to provide intensive, hands-on training in a highly targeted clinical research topic area in a very interactive and engaging learning environment. To view more details and available courses, click here.

BARNETT CATALOGThe Barnett Catalogue is your comprehensive guide to the myriad live, web, and custom training opportunities offered throughout the year.

Jan - Jul 2013 Edition

Download Today!